Plasma Versus Tissue Tumor Mutational Burden As Biomarkers of Durvalumab Plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Clinical Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined